Investor profile
Claris Ventures has backed 5 European tech companies across 6 funding rounds between 2022 and 2024, joining rounds totalling €70M. Most active in Healthtech. Data as of 7 Aug 2026.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
| Company | Country | Rounds | Total € |
|---|---|---|---|
| Sibylla Biotech | Italy | 1 | €23M |
| Resalis Therapeutics | Italy | 2 | €20M |
| Kither Biotech | Italy | 1 | €19M |
| NeoPhore | UK | 1 | €6.8M |
| Repron Therapeutics | Italy |
| Company | Stage | Amount | Date |
|---|---|---|---|
| Sibylla Biotech | Series A | €23M | 2022-10 |
| Kither Biotech | Series B | €19M | 2022-03 |
| Resalis Therapeutics | Series A | €10M | 2024-01 |
| Resalis Therapeutics |
| 1 |
| €2.0M |
| Seed |
| €10M |
| 2023-02 |
| NeoPhore | Series B | €6.8M | 2023-01 |
| Repron Therapeutics | Seed | €2.0M | 2023-06 |
